Laura Parkkinen Selected Research

Laura Parkkinen Research Topics

19	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2005
12	Dementia (Dementias) 12/2021 - 01/2005
6	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2017 - 01/2005
5	Synucleinopathies 01/2022 - 01/2005
4	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 04/2003
3	Parkinsonian Disorders (Parkinsonism) 10/2017 - 02/2014
2	Disease Progression 01/2022 - 01/2014
2	Multiple System Atrophy 01/2022 - 07/2015
1	Intellectual Disability (Idiocy) 10/2017
1	Cognitive Dysfunction 11/2011
1	Disorders of Excessive Somnolence (Hypersomnia) 11/2011
1	Hallucinations (Hallucination) 11/2011
1	Gaucher Disease (Gaucher's Disease) 07/2009

10	SynucleinsIBA 01/2022 - 05/2011
9	alpha-SynucleinIBA 01/2022 - 04/2003
6	Proteins (Proteins, Gene)FDA Link 07/2015 - 01/2005
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2014
2	Apolipoproteins E (ApoE)IBA 01/2019 - 12/2014
2	Amyloid (Amyloid Fibrils)IBA 01/2014 - 05/2011
2	Glucosylceramidase (Glucocerebrosidase)IBA 08/2011 - 07/2009
2	Amyloid beta-PeptidesIBA 01/2008 - 12/2005
1	Poly TIBA 01/2019
1	dextran-2-hydroxy-3-mercaptopropyl ether (C 79)IBA 10/2017
1	Dihydroxyphenylalanine (Dopa)IBA 10/2017
1	Levodopa (L Dopa)FDA LinkGeneric 10/2017
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2017
1	Leucine (L-Leucine)FDA Link 11/2016
1	Phosphotransferases (Kinase)IBA 11/2016
1	AntibodiesIBA 07/2015
1	Dopamine (Intropin)FDA LinkGeneric 02/2014
1	Dopamine Agents (Dopaminergic Agents)IBA 11/2011
1	EpitopesIBA 12/2005

1	Duration of Therapy 11/2011